ginsenoside rh2 has been researched along with su 11248 in 1 studies
Studies (ginsenoside rh2) | Trials (ginsenoside rh2) | Recent Studies (post-2010) (ginsenoside rh2) | Studies (su 11248) | Trials (su 11248) | Recent Studies (post-2010) (su 11248) |
---|---|---|---|---|---|
295 | 1 | 200 | 4,338 | 560 | 3,200 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 1 (100.00) | 2.80 |
Authors | Studies |
---|---|
Hong, SH; Hwang, HJ; Moon, HS; Park, SY; Yoon, YE | 1 |
1 other study(ies) available for ginsenoside rh2 and su 11248
Article | Year |
---|---|
Ginsenoside Rh2 sensitizes the anti-cancer effects of sunitinib by inducing cell cycle arrest in renal cell carcinoma.
Topics: Carcinoma, Renal Cell; Cell Cycle Checkpoints; Ginsenosides; Humans; Kidney Neoplasms; Sunitinib | 2022 |